SKI Market

A+| A| A-|

Indian Indices

Sensex

75,183.36 -135.03
( -0.18%)

Global Indices

Nasdaq

50,030.26 645.37
(1.31%)

Dow Jones

7,453.29 78.68
(1.07%)

Hang Seng

61,747.25 1,942.84
(3.25%)

Nikkei 225

10,466.07 33.73
(0.32%)

Forex

USD-INR

96.52 0.30
(0.32%)

EUR-INR

112.16 0.19
(0.17%)

GBP-INR

129.37 0.68
(0.52%)

JPY-INR

0.61 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

61.2618363

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

30.31

23447.94

EPS(TTM)

Face Value()

Div & Yield %

5.82

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	5285.71	4390.11	3443.22	3340.42	2938.81
Excise Duty	0.00	0.00	0.00	0.00	0.00
Net Sales	5285.71	4390.11	3443.22	3340.42	2938.81
Other Income	207.35	202.06	341.07	224.79	216.20
Stock Adjustments	84.57	61.62	-53.31	32.66	-57.86
Total Income	5577.63	4653.79	3730.98	3597.87	3097.15
EXPENDITURE :
Raw Materials	2330.53	2170.46	1715.17	1594.17	1169.91
Power & Fuel Cost	131.62	112.89	107.94	83.83	68.08
Employee Cost	736.19	613.93	548.50	448.03	395.15
Other Manufacturing Expenses	284.35	251.57	259.29	299.83	252.74
Selling & Administrative Expenses	746.69	620.04	485.63	427.82	258.75
Miscellaneous Expenses	100.46	64.92	182.81	59.20	117.39
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00
Total Expenditure	4329.84	3833.81	3299.34	2912.88	2262.02
Operating Profit	1247.79	819.98	431.64	684.99	835.13
Interest	114.56	107.10	115.87	57.29	4.71
Gross Profit	1133.23	712.88	315.77	627.70	830.42
Depreciation	222.09	205.26	192.08	165.37	143.64
Profit Before Tax	911.14	507.62	123.69	462.33	686.78
Tax	199.44	112.48	38.77	110.82	104.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.30	3.92	15.42	-16.03	10.30
Reported Net Profit	691.40	391.22	69.50	367.54	571.50
Extraordinary Items	1.24	3.34	-3.14	-10.64	15.44
Adjusted Net Profit	690.16	387.88	72.64	378.18	556.06
Adjustment below Net Profit	1.05	-3.79	-2.59	31.70	-2.46
P & L Balance brought forward	1359.23	971.79	918.28	569.04	0.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00
Appropriations	14.47	0.00	13.40	50.00	0.00
P & L Balance carried down	2037.21	1359.22	971.79	918.28	569.04
Dividend	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1.40	1.10	0.00	5.60	0.00
Dividend Per Share(Rs)	0.14	0.11	0.00	0.56	0.00
Earnings Per Share-Unit Curr	5.22	2.96	0.58	3.10	5.75
Earnings Per Share(Adj)-Unit Curr	5.22	2.96	0.57	3.10	5.75
Book Value-Unit Curr	56.27	50.74	44.09	43.20	41.23
Book Value(Adj)-Unit Curr	56.27	50.74	43.06	43.20	41.23

75,183.36 -135.03 ( -0.18%)

50,030.26 645.37 (1.31%)

7,453.29 78.68 (1.07%)

61,747.25 1,942.84 (3.25%)

10,466.07 33.73 (0.32%)

96.52 0.30 (0.32%)

112.16 0.19 (0.17%)

129.37 0.68 (0.52%)

0.61 0.00 (0.22%)